VCA Stocks

OPX Biotechnologies, Inc., a new company dedicated to enabling economically viable biofuels and biorefined chemicals, announced today that it has secured $3.6 million in venture funding.  Using a proprietary set of tools and IP known as SCALEs that enable massively parallel full genome search, identification of specific causative genes, and rapid genetic modification and testing, OPX can quickly engineer new microbes to provide major improvements in tolerance, productivity, and specificity for fuel and chemicals production using biological processes. The company’s mission is to be the world’s leading microbe engineering company and to use its technology to vastly decrease the production costs and capital requirements for renewal fuels and chemicals.